Try our corporate solution for free!
(212) 419-8286

Leading pharmaceutical companies by global vaccine revenue 2019

GlaxoSmithKline generated approximately 9.1 billion U.S. dollars from vaccine sales in 2019, making it the largest vaccine company in the world based on revenue. The British pharmaceutical giant topped the ranking ahead of competitors Merck & Co. and Pfizer.

Analyzing vaccine sales of leading companies

GlaxoSmithKline reported an annual revenue of 33.7 billion British pounds in 2019 – vaccine sales accounted for around 20 percent of that figure. Year-on-year sales of Shingrix, the company’s shingles vaccine, more than doubled to 1.8 billion British pounds. The leading vaccine of Merck & Co. is Gardasil/Gardasil 9, which can help in the prevention of certain cancers. The vaccine is one of Merck’s top-selling products and accounted for almost 50 percent of the company’s total vaccine sales. Pfizer generated vaccine sales of 6.5 billion U.S. dollars in 2019. The pneumococcal vaccine Prevnar 13/Prevenar 13 was the company’s top product based on revenue during the year.

The race for a coronavirus vaccine

Despite recent growth in the global vaccine market, there are only four big pharma companies with substantial vaccine operations. However, the ongoing COVID-19 pandemic has highlighted the critical importance of vaccine research and development. Aided by government funding and partnerships, several smaller companies have entered the race to find a cure for the disease. Biotech company Moderna is applying its pioneering mRNA research to the problem and hopes the vaccine successfully passes each phase of the clinical trials.

Leading companies based on global vaccine revenue in 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

March 2020



Survey time period


Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Vaccinations in Germany"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.